The IPO Outlook For The Week: Shipping, Medtech, Mobility And Retail

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud.

Hyrecar Inc. HYRE will issue 2 million shares between $5 and $6 Wednesday on the Nasdaq. The firm facilitates vehicle rentals between car owners and Uber and Lyft drivers.

Neon Therapeutics, Inc. NTGN will issue 6.25 million shares between $15 and $17 Wednesday on the Nasdaq. Based in Massachusetts, the oncology company develops personalized neoantigen-targeted therapies and vaccines through its proprietary platform.

Uxin Ltd UXIN will issue 38 million shares between $10.50 and $12.50 Wednesday on the Nasdaq. China’s used-car auction platform has provided business-to-business and business-and-consumer services since 2011.

BJ’s Wholesale Club Holdings, Inc. BJ will issue 37.5 million shares between $15 and $17 Thursday on the New York Stock Exchange. Headquartered in Massachusetts, the Beacon Holding subsidiary operates more than 210 membership warehouse clubs in 16 east-coast states.

Brightview Holdings, Inc. BV will issue 21.3 million shares between $22 and $25 Thursday on the New York Stock Exchange. The four-year-old product of Brickman and ValleyCrest develops, maintains and enhances commercial and residential landscapes.

Everquote, Inc. EVER will issue nearly 4.7 million shares between $15 and $17 Thursday on the Nasdaq. The tech firm connects consumers with personalized insurance options and streamlines the buying process.

Forty Seven, Inc. FTSV will issue 6.7 million shares between $14 and $16 Thursday on the Nasdaq. Since 2015, Forty Seven has been advancing CD47-blocking antibodies to destroy cancer cells and increase patient survival rates.

Goodbulk Ltd. GBLK will issue 8.5 million shares between $15.50 and $17.50 Thursday on the Nasdaq. The Monaco-based firm owns 25 dry bulk vessels managed by C Transport Maritime SAM.

Neuronetics, Inc. STIM will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. The commercial-stage med-tech company develops and markets non-drug treatments for psychiatric disorders, including major depressive disorder.

Translate Bio, Inc. TBIO will issue 7.7 million shares between $12 and $14 Thursday on the Nasdaq. The mRNA therapeutics company develops treatments for cystic fibrosis, OTC deficiency, and rare liver, lung and neurological diseases.

Tricida, Inc. TCDA will issue 10.3 million shares between $16 and $18 Thursday on the Nasdaq. The clinical-stage biopharmaceutical company develops and commercializes therapies for chronic kidney disease and metabolic acidosis.

Domo, Inc. DOMO will issue 9.2 million shares between $19 and $22 Friday on the Nasdaq. With clients like eBay Inc EBAY and Mastercard Inc MA, Domo’s analytics platform aggregates company records, provides actionable insights and enables real-time data engagement for all employees.

Related Links:

5 Reasons Why 2018 Could Be Good For IPO ETFs

3 Tech IPOs We Want In 2018